FSB Premier Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
4,605
+145
+3% +$47.7K 0.42% 62
2025
Q4
$1.56M Sell
4,460
-1,088
-20% -$368K 0.5% 56
2025
Q3
$1.79M Buy
5,548
+1,615
+41% +$502K 0.59% 51
2025
Q2
$1.53M Buy
3,933
+531
+16% +$214K 0.55% 48
2025
Q1
$1.48M Buy
3,402
+558
+20% +$224K 0.58% 47
2024
Q4
$1.05M Buy
2,844
+329
+13% +$138K 0.42% 62
2024
Q3
$1.31M Buy
2,515
+601
+31% +$321K 0.54% 46
2024
Q2
$1.04M Buy
1,914
+826
+76% +$437K 0.47% 50
2024
Q1
$564K Buy
1,088
+451
+71% +$224K 0.26% 85
2023
Q4
$300K Buy
+637
New +$295K 0.15% 128
2023
Q1
Sell
-491
Closed -$252K 150
2022
Q4
$252K Buy
+491
New +$249K 0.14% 127
2022
Q1
Sell
-629
Closed -$291K 256
2021
Q4
$291K Buy
+629
New +$265K 0.12% 110

Other funds holding ELV

FSB Premier Wealth Management's ELV Position: Q1 2026 in Review

FSB Premier Wealth Management increased its Elevance Health (ELV) stake by 3.3% in Q1 2026, buying an estimated $47.7K and bringing the position to 4,605 shares worth $1.35M. The position accounts for 0.42% of the portfolio, ranked #62.

FSB Premier Wealth Management first reported a position in ELV in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.79M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • FSB Premier Wealth Management held 4,605 shares of Elevance Health worth $1.35M as of Q1 2026.
  • FSB Premier Wealth Management bought 145 Elevance Health shares in Q1 2026, an estimated $47.7K.
  • Elevance Health made up 0.42% of FSB Premier Wealth Management's portfolio in Q1 2026, its #62 holding.
  • FSB Premier Wealth Management first reported a position in Elevance Health in Q4 2021 and has held it in 12 quarters since.
  • FSB Premier Wealth Management's Elevance Health position peaked at $1.79M in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.